Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NP-101 for the Treatment of Patients with Advanced or Metastatic, Relapsed Solid Tumors

Trial Status: active

This phase I trial tests the safety, side effects, and best dose of NP-101 for the treatment of patients with solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic), and that has come back after a period of improvement (relapsed). NP-101, also called black seed or black cumin, is an oil extracted from seeds that may enhance the body's immune response and kill tumor cells.